Get the Stockscreener App
1.34
10.67%
-0.16
After Hours:
1.36
0.02
+1.49%
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Forecast
The Reviva Pharmaceuticals Holdings Inc (RVPH) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.1568, representing a -13.67% decrease from the current price of $1.34. The highest analyst price target is $1.2068, and the lowest is $1.1068.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RVPH Price Target
Average 1.5552
(+16.06% Upside)
Is Reviva Pharmaceuticals Holdings Inc (RVPH) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 43.91 | Neutral |
| STOCH(9,6) | 18.36 | Buy |
| STOCHRSI(14) | 5.0606 | Buy |
| MACD(12,26) | 0.1219 | Sell |
| ADX(14) | 35.24 | Buy |
| William %R | -93.93 | Buy |
| CCI(14) | -61.76 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.081
Sell
|
1.7505
Sell
|
| MA20 |
1.6655
Sell
|
1.69
Sell
|
| MA50 |
1.3712
Sell
|
1.4799
Sell
|
| MA100 |
1.2393
Buy
|
1.4591
Sell
|
| MA200 |
1.7036
Sell
|
1.9315
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, RVPH could be considered a Strong Sell, with 17 technical analysis indicators signaling 5 Buy signals, 10 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on RVPH, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 43.91 indicates that RVPH is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 18.36 indicates that RVPH is oversold. This indicates that RVPH price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 5.0606 indicates that RVPH is oversold. This suggests that RVPH price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 35.24 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -61.76 indicates that RVPH is still oversold but not to an extreme extent.
Long-term RVPH price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Reviva Pharmaceuticals Holdings Inc financial reports and earnings history, Reviva Pharmaceuticals Holdings Inc (RVPH) stock could reach $6.5959 by 2030, $19.42 by 2040 and $14.23 by 2050. See the projected annual prices until 2050 of the Reviva Pharmaceuticals Holdings Inc stock below:
- Reviva Pharmaceuticals Holdings Inc (RVPH) is expected to reach an average price of $3.0422 in 2035, with a high prediction of $3.8721 and a low estimate of $3.2922. This indicates an $127.03% rise from the last recorded price of $1.34.
- Reviva Pharmaceuticals Holdings Inc (RVPH) stock is projected to chart a bullish course in 2040, with an average price target of $19.74, representing an $1,373% surge from its current level. The forecast ranges from a conservative $19.95 to a sky-high $19.42.
- Our analysts predict Reviva Pharmaceuticals Holdings Inc (RVPH) to jump 1,560% by 2045, soaring from $21.89 to an average price of $22.24, potentially reaching $22.01. While $21.89 is the low estimate, the potential upside is significant.
- Reviva Pharmaceuticals Holdings Inc (RVPH) stock is expected to climb by 2050, reaching an average of $14.81, a $1,005% jump from its current level. However, a wide range of estimates exists, with high and low targets of $14.23 and $14.56, respectively, highlighting the market's uncertainty.
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Year by Year Forecast
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Price Forecast for 2025
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) is expected to reach an average price of $1.5552 in 2025, with a high prediction of $2.5803 and a low estimate of $0.5302. This indicates an +16.06% rise from the last recorded price of $1.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.3068 | $1.1068 | $1.2068 | -77.10% |
| February, 2025 | $0.2202 | $0.5302 | $0.21 | -83.57% |
| March, 2025 | $0.7835 | $0.6269 | $0.4535 | -41.53% |
| April, 2025 | $1.1002 | $0.8869 | $0.8602 | -17.89% |
| May, 2025 | $0.6736 | $1.0036 | $0.5636 | -49.73% |
| June, 2025 | $1.3869 | $1.5203 | $1.3236 | +3.50% |
| July, 2025 | $2.4736 | $2.4003 | $2.5803 | +84.60% |
| August, 2025 | $2.277 | $2.337 | $2.367 | +69.92% |
| September, 2025 | $2.0103 | $2.3824 | $2.257 | +50.02% |
| October, 2025 | $1.967 | $1.727 | $1.827 | +46.79% |
| November, 2025 | $2.2404 | $2.1304 | $2.1904 | +67.19% |
| December, 2025 | $2.7071 | $2.1904 | $2.4771 | +102.02% |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Price Forecast for 2026
The predicted value for Reviva Pharmaceuticals Holdings Inc (RVPH) in 2026 is set at an average of $3.1094. Estimates vary from a peak of $6.2093 to a trough of $0.00948, indicating an +132.04% surge from the present price of $1.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.7004 | $2.7071 | $2.6204 | +101.52% |
| February, 2026 | $3.1289 | $2.8237 | $2.9538 | +133.50% |
| March, 2026 | $1.5171 | $2.2071 | $3.0071 | +13.22% |
| April, 2026 | $2.0338 | $1.5338 | $1.7485 | +51.78% |
| May, 2026 | $0.2428 | $0.5372 | $1.1771 | -81.88% |
| June, 2026 | $1.1695 | $0.2445 | $2.5928 | -12.72% |
| July, 2026 | $0.3428 | $0.00948 | $1.4586 | -74.42% |
| August, 2026 | $1.0495 | $0.1905 | $1.0895 | -21.68% |
| September, 2026 | $1.4428 | $0.8128 | $1.8561 | +7.67% |
| October, 2026 | $1.3794 | $0.8895 | $1.8161 | +2.94% |
| November, 2026 | $1.0661 | $0.3761 | $1.6161 | -20.44% |
| December, 2026 | $5.5094 | $0.9927 | $6.2093 | +311.15% |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Reviva Pharmaceuticals Holdings Inc (RVPH) is $3.4098, with a high forecast of $6.1938 and a low forecast of $0.6258. This indicates an +154.46% increase from the last price of $1.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.136 | $1.956 | $6.1938 | +134.03% |
| February, 2027 | $2.9227 | $2.3927 | $5.0593 | +118.11% |
| March, 2027 | $1.776 | $1.096 | $3.1093 | +32.54% |
| April, 2027 | $1.3726 | $1.121 | $2.0293 | +2.44% |
| May, 2027 | $1.8493 | $0.876 | $2.6093 | +38.01% |
| June, 2027 | $1.9026 | $1.7426 | $3.3759 | +41.98% |
| July, 2027 | $2.3192 | $0.9694 | $4.2426 | +73.08% |
| August, 2027 | $1.3559 | $1.2859 | $3.7927 | +1.19% |
| September, 2027 | $2.7592 | $1.1525 | $3.0492 | +105.91% |
| October, 2027 | $1.5458 | $1.4358 | $3.2959 | +15.36% |
| November, 2027 | $2.0425 | $1.3392 | $2.5725 | +52.43% |
| December, 2027 | $0.9758 | $0.6258 | $2.2592 | -27.18% |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Price Forecast for 2028
In 2028, Reviva Pharmaceuticals Holdings Inc (RVPH) is projected to reach an average price of $3.2381, with a high projection of $5.9636 and a low estimate of $0.5125. This indicates an +141.65% rise from the last price of $1.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.5825 | $0.5125 | $1.9291 | +18.09% |
| February, 2028 | $1.1674 | $0.8258 | $1.5091 | -12.88% |
| March, 2028 | $1.6467 | $1.78 | $1.6267 | +22.89% |
| April, 2028 | $1.7634 | $1.7967 | $1.4844 | +31.60% |
| May, 2028 | $4.3468 | $2.4801 | $2.1018 | +224.39% |
| June, 2028 | $5.7035 | $4.5635 | $5.0335 | +325.63% |
| July, 2028 | $5.1502 | $5.0435 | $5.7402 | +284.34% |
| August, 2028 | $4.9136 | $5.1252 | $4.6636 | +266.68% |
| September, 2028 | $5.1103 | $4.9669 | $4.8903 | +281.36% |
| October, 2028 | $6.127 | $5.6969 | $5.947 | +357.24% |
| November, 2028 | $5.0504 | $5.2204 | $5.9636 | +276.89% |
| December, 2028 | $5.1871 | $5.2671 | $4.8337 | +287.09% |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Price Forecast for 2029
The 2029 price forecast for Reviva Pharmaceuticals Holdings Inc Stock (RVPH) is $6.0522 on average, with a high prediction of $6.8706 and a low estimate of $5.2337. This represents an +351.65% increase from the previous price of $1.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.5704 | $5.2337 | $5.4004 | +315.70% |
| February, 2029 | $5.1671 | $5.3938 | $5.0571 | +285.61% |
| March, 2029 | $5.9238 | $5.4272 | $5.0938 | +342.08% |
| April, 2029 | $6.6505 | $5.9105 | $5.6972 | +396.31% |
| May, 2029 | $6.8039 | $6.8439 | $6.8706 | +407.76% |
| June, 2029 | $6.4806 | $6.5439 | $6.4673 | +383.63% |
| July, 2029 | $5.7873 | $6.1172 | $6.414 | +331.89% |
| August, 2029 | $5.9907 | $5.834 | $5.8917 | +347.07% |
| September, 2029 | $6.2374 | $6.3074 | $6.1807 | +365.48% |
| October, 2029 | $6.6308 | $6.1308 | $6.5108 | +394.83% |
| November, 2029 | $6.6375 | $6.5641 | $6.4575 | +395.34% |
| December, 2029 | $6.8042 | $6.6483 | $6.7642 | +407.78% |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Price Forecast for 2030
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) is expected to reach an average price of $3.3289 in 2030, with a high forecast of $6.5959 and a low forecast of $0.062. This signifies an +148.43% surge from the last price of $1.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.1776 | $5.2076 | $6.5959 | +286.39% |
| February, 2030 | $4.8843 | $5.3442 | $5.3723 | +264.50% |
| March, 2030 | $3.161 | $3.296 | $3.1643 | +135.89% |
| April, 2030 | $2.9677 | $2.2943 | $2.0153 | +121.47% |
| May, 2030 | $3.5311 | $3.3244 | $3.081 | +163.51% |
| June, 2030 | $2.2278 | $2.3878 | $2.4677 | +66.25% |
| July, 2030 | $1.7311 | $1.9978 | $1.8744 | +29.19% |
| August, 2030 | $1.9378 | $1.8212 | $1.5812 | +44.62% |
| September, 2030 | $1.6845 | $2.1145 | $2.0369 | +25.71% |
| October, 2030 | $1.2921 | $0.4446 | $3.1699 | -3.58% |
| November, 2030 | $0.8654 | $0.1554 | $2.2854 | -35.42% |
| December, 2030 | $0.0787 | $0.062 | $2.1187 | -94.13% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):